Understanding Lupus Anticoagulant (dRVVT) Normalized Ratio: Normal vs Optimal Ranges

Also known as: dilute russell viper venom time, drvvt, lupus anticoagulant, la

Coagulation & ThrombosisUnit: ratio

?What is Lupus Anticoagulant (dRVVT) Normalized Ratio?

The lupus anticoagulant (dRVVT) normalized ratio is a specialized coagulation test that detects lupus anticoagulant antibodies, which paradoxically prolong blood clotting time in vitro despite increasing clot risk in vivo. The test uses dilute Russell viper venom time and is expressed as a normalized ratio comparing patient plasma to normal control plasma. It is commonly used to evaluate thrombophilia and autoimmune conditions.

!Why It Matters

An elevated lupus anticoagulant ratio may suggest increased risk of thrombosis (blood clots) and recurrent miscarriage, and can be associated with antiphospholipid syndrome and systemic lupus erythematosus. Detecting this antibody is important for identifying individuals at risk for clotting complications and guiding anticoagulation management.

Reference Ranges

Range TypeMinMaxUnitNote
Lab Normal1.2ratioStandard lab reference range
Optimal1.1ratioEvidence-based optimal range for health
Longevity Target1.1ratioPer longevity medicine research (Attia et al.)

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

  • Recurrent blood clots (deep vein thrombosis or pulmonary embolism)
  • Recurrent miscarriage or pregnancy complications
  • Unexplained prolonged bleeding time
  • Joint or muscle pain
  • Skin rashes or photosensitivity

How to Improve Your Levels

  • 1Work with a hematologist or rheumatologist to establish appropriate anticoagulation therapy if indicated
  • 2Monitor for signs of thrombosis and follow prescribed anticoagulation protocols
  • 3Maintain adequate hydration to support cardiovascular health
  • 4Avoid immobility for prolonged periods; engage in regular moderate physical activity
  • 5Manage underlying autoimmune conditions with appropriate medical supervision
  • 6Attend regular follow-up testing and clinical monitoring appointments

When to Test

Testing is indicated when evaluating recurrent thrombosis, recurrent pregnancy loss, prolonged activated partial thromboplastin time (aPTT), suspected antiphospholipid syndrome, or systemic lupus erythematosus. Serial testing may be performed to confirm persistent positivity and assess clotting risk.

Related Biomarkers

Track your Lupus Anticoagulant (dRVVT) Normalized Ratio with ByoMap

Upload your blood report and get personalized Lupus Anticoagulant (dRVVT) Normalized Ratio ranges based on your age, sex, and ancestry — free.

Try Free — Upload Your Report